InvestorsHub Logo
Followers 24
Posts 1336
Boards Moderated 0
Alias Born 11/15/2016

Re: None

Wednesday, 01/30/2019 8:46:41 PM

Wednesday, January 30, 2019 8:46:41 PM

Post# of 203921
I’m interested to see efficacy results that start this quarter on the sublingual tablet against chronic pain syndrome. Also, I am excited how it will compare with GWPH ‘s drug if their amendment is granted. Zevi is also pushing MM along. So many reasons to keep a core amount of shares.